3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neurofibromatosis 1
9
Neurofibroma, Plexiform
6
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Pancreatic Neoplasms
1
Pain
1
Neurofibrosarcoma
1
Kidney Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Astrocytoma
1
Advanced Non Small Cell Lung Cancer
1
Adenocarcinoma
1
Interventions
pembrolizumab
53
Paclitaxel
20
Cisplatin
15
Carboplatin
15
lenvatinib
10
Docetaxel
9
Saline Solution
7
Capecitabine
7
Pemetrexed
6
Oxaliplatin
6
Gemcitabine
6
Fluorouracil
6
Leucovorin
5
Albumin-Bound Paclitaxel
5
olaparib
4
belzutifan
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
patritumab deruxtecan
3
Glucose
3
Acetaminophen
3
liposomal doxorubicin
2
Levoleucovorin
2
Irinotecan
2
Histamine H2 Antagonists
2
Histamine Antagonists
2
Etoposide
2
Doxorubicin
2
Dexamethasone
2
Cetuximab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
AZD 6244
×
90 days
×
Clear all
No trials found.